Related Experiment Videos

Additional markers to refine the World Health Organization algorithm for diagnosis of pneumonia

A V Castro1, C M Nascimento-Carvalho, F Ney-Oliveria

  • 1Departments of Pediatrics and Radiodiagnosis, Federal University of Bahia and the Emergency Department, Jorge Valente Hospital, Salvador, Bahia, Brazil.

Indian Pediatrics
|September 6, 2005
PubMed

Insights

This study suggests that evaluating a child's history of respiratory distress, fever, chest indrawing, and response to bronchodilators (BD) can help accurately diagnose pneumonia in children with tachypnea, potentially reducing antibiotic overuse.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Disease Management
  • Respiratory Medicine

Background:

  • Current World Health Organization (WHO) guidelines recommend antibiotics for all children with tachypnea, leading to overuse.
  • Refining diagnostic criteria for pneumonia in children presenting with tachypnea is crucial.

Purpose of the Study:

  • To assess the utility of clinical history (previous respiratory distress), physical examination findings (fever, chest indrawing), and bronchodilator (BD) response in diagnosing pneumonia.
  • To refine existing guidelines for managing pediatric tachypnea.

Main Methods:

  • Prospective study involving 165 children (6-59 months) with cough and tachypnea.
  • Chest X-rays interpreted by blinded radiologists; clinical data including fever, chest indrawing, and BD response were recorded.
  • Association between persistent tachypnea after BD and pulmonary infiltrates was analyzed.

Main Results:

  • Pneumonia was diagnosed in 15.8% of children.
  • History of previous respiratory distress was associated with a higher pneumonia diagnosis rate (19.2% vs 5%).
  • Persistent tachypnea after BD was significantly associated with pulmonary infiltrates (P=0.02), with a negative predictive value of 87.3% for tachypnea resolution.

Conclusions:

  • Combining clinical history, fever, chest indrawing, and BD response can reliably identify pneumonia in children with tachypnea.
  • This refined approach may significantly decrease unnecessary antibiotic prescriptions for pediatric respiratory infections.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: